Initial Real-World Experience With Cenobamate in Adolescents and Adults: A Single Center Experience

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial

Gregory L. Krauss, Pavel Klein, Christian Brandt et al. · The Lancet Neurology · 2019 · 332 citations

Medicine, Neurology, Pharmacology +13

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study

Michael R. Sperling, Pavel Klein, Sami Aboumatar et al. · Epilepsia · 2020 · 211 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy

Christopher T. Buckley, Olivia R. Waters, George DeMaagd · Annals of Pharmacotherapy · 2020 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +15

Impact of Drug Interactions on Clobazam and N-Desmethylclobazam Concentrations in Pediatric Patients With Epilepsy

Gabrielle R. Russell, Stephanie J. Phelps, Chasity M. Shelton et al. · Therapeutic Drug Monitoring · 2018 · 13 citations

Medicine, Pharmacokinetics, Pharmacology +16